Farmers & Merchants Investments Inc’s Corcept Therapeutics CORT Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.78K	Hold	55	–	–	﹤0.01%	1016
2026 Q1	$2.22K	Hold	55	–	–	﹤0.01%	1223
2025 Q4	$1.91K	Hold	55	–	–	﹤0.01%	1245
2025 Q3	$4.57K	Hold	55	–	–	﹤0.01%	1008
2025 Q2	$4.04K	Sell	55 -6	-10%	-$435	﹤0.01%	1013
2025 Q1	$6.97K	Hold	61	–	–	﹤0.01%	785
2024 Q4	$3.07K	Sell	61 -4	-6%	-$210	﹤0.01%	951
2024 Q3	$3.01K	Hold	65	–	–	﹤0.01%	973
2024 Q2	$2.11K	Hold	65	–	–	﹤0.01%	1117
2024 Q1	$1.64K	Hold	65	–	–	﹤0.01%	1221
2023 Q4	$2.11K	Hold	65	–	–	﹤0.01%	1072
2023 Q3	$1.77K	Sell	65 -8	-11%	-$232	﹤0.01%	1085
2023 Q2	$1.62K	Hold	73	–	–	﹤0.01%	1176
2023 Q1	$1.58K	Hold	73	–	–	﹤0.01%	1178
2022 Q4	$1.48K	Buy	73 +9	+14%	+$226	﹤0.01%	1211
2022 Q3	$2K	Buy	+64	New	+$1.71K	﹤0.01%	949
2019 Q1	–	Sell	-453	Closed	-$6K	–	843
2018 Q4	$6K	Hold	453	–	–	﹤0.01%	593
2018 Q3	$6K	Hold	453	–	–	﹤0.01%	667
2018 Q2	$7K	Buy	453 +73	+19%	+$1.27K	﹤0.01%	616
2018 Q1	$6K	Buy	+380	New	+$7.04K	﹤0.01%	640

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

FWP

FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Farmers & Merchants Investments Inc's CORT Position: Q2 2026 in Review

Farmers & Merchants Investments Inc held its Corcept Therapeutics (CORT) position steady in Q2 2026 at 55 shares worth $4.78K. The position accounts for ﹤0.01% of the portfolio, ranked #1016.

Farmers & Merchants Investments Inc first reported a position in CORT in Q1 2018 and has held it in 20 quarters since. The position peaked at $7K in Q2 2018. 193 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Farmers & Merchants Investments Inc held 55 shares of Corcept Therapeutics worth $4.78K as of Q2 2026.
Farmers & Merchants Investments Inc left its Corcept Therapeutics share count unchanged in Q2 2026.
Corcept Therapeutics made up ﹤0.01% of Farmers & Merchants Investments Inc's portfolio in Q2 2026, its #1016 holding.
Farmers & Merchants Investments Inc first reported a position in Corcept Therapeutics in Q1 2018 and has held it in 20 quarters since.
Farmers & Merchants Investments Inc's Corcept Therapeutics position peaked at $7K in Q2 2018.
193 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Farmers & Merchants Investments Inc's 13F filing for Q2 2026, filed 20 Jul 2026.